Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis

Published:2022-07 Issue: Volume:108 Page:108848
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Chen Ching-Yi,Huang Chi-Hsien,Chen Wang-Chun,Huang Ming-Shyan,Wei Yu-Feng

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference46 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Shifting paradigms in non-small cell lung cancer: an evolving therapeutic landscape;Riessk;Am. J. Manag. Care,2013

3. Immunotherapy for lung cancer;Steven;Respirology,2016

4. Advances in cancer immunology and cancer immunotherapy;Voena;Discov. Med.,2016

5. U.S. Food and Drug Administration: FDA approves nivolumab plus ipilimumab and chemotherapy for first-line treatment of metastatic NSCLC. .

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system;Frontiers in Immunology;2024-04-30

2. Immune-related adverse events of immune checkpoint inhibitors: a review;Frontiers in Immunology;2023-05-25

3. Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management;Expert Review of Clinical Pharmacology;2023-05-04

4. Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study;Frontiers in Pharmacology;2023-04-13

5. The safety of combining immune checkpoint inhibitors and platinum-based chemotherapy for the treatment of solid tumors: A systematic review and network meta-analysis;Frontiers in Immunology;2023-02-07